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Medicalization analyses have roots in sociology and have critical usefulness for understanding contemporary
health issues including the ‘post-2015 global health agenda’. Medicalization is more complex than just ‘disease
mongering’  it is a process and not only an outcome; has both positive and negative elements; can be partial
ratherthancomplete; andisoften soughtorchallengedbypatients orothers inthehealthfield. Itisunderstood
tobeexpandingratherthancontracting,playsoutatthelevelofinteractionorofdefinitionsandagenda-setting,
and is said to be largely harmful and costly to individuals and societies. Medicalization of global health issues
would overemphasise the role of health care to health; define and frame issues in relation to disease, treatment
strategies,andindividualbehaviour;promotetheroleofmedicalprofessionalsandmodelsofcare;findsupport
in industry or other advocates of technologies and pharmaceuticals; and discount social contexts, causes, and
solutions.Insubsequentarticles,threecasestudiesareexplored,whichcriticallyexaminepredominantissueson
the global health agenda: global mental health, non-communicable disease, and universal health coverage. A
medicalization lens helps uncover areaswhere the global health agenda and its framing of problems are shifted
toward medical and technical solutions, neglecting necessary social, community, or political action.
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M
edicalization is a process by which human
problems come to be defined and treated as
medical problems. It involves the application
of a biomedical model that sees health as freedom from
disease and is characterised by reductionism, individual-
ism, and a bias toward the technological (Box 1). Critical
examinations of medicalization and its limitations for un-
derstanding health owe much to a long tradition of study
by sociologists who have uncovered the ways that such
varied conditions as addiction, childbirth, infant feeding,
sadness, erectile dysfunction, and death have become
medical issues to be treated (16). Traditionally, medica-
lization was seen to be fuelled by the medical profession
and doctors, whose cultural authority and power allowed
them to grow medical jurisdiction over people’s health
and society, resulting in what Illich described as ‘medical
imperialism’ (7). More recent analyses affirm the medi-
calization of many aspects of life and identify the
changing drivers, particularly in the United States and
Europe: pharmaceutical industry interests, the rise of
biotechnology and genomics, and health systems like
‘managed care’ that limit provision or choice, all of which
wield increasing power for defining ‘legitimate’ health
problems (8, 9). Some commentators have drawn upon
insights from medicalization analyses to identify over-
diagnosis and ‘disease mongering’, particularly by the
pharmaceutical industry intent on creating new disease
categories to sell drugs (10).
Contemporarysociologicalanalysesrecognisecomplex-
ity in medicalization: the fact that medicalization is a
process not just an outcome, it can be both positive and
negative, partial rather than complete, and can be sought
by patients, doctors or other actors in the health field,
as well as be resisted or challenged (8, 11, 12). Never-
theless, the consequences of medicalization are largely
seen to be negative for both individuals and societies
Global Health Action
Global Health Action 2014. # 2014 Jocalyn Clark. This is an Open Access article distributed under the terms of the Creative Commons CC-BY 4.0 License
(http://creativecommons.org/licenses/by/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix,t r a n s f o r m ,a n d
build upon the material for any purpose, even commercially, provided the original work is properly cited and states its license.
1
Citation: Glob Health Action 2014, 7: 23998 - http://dx.doi.org/10.3402/gha.v7.23998
(page number not for citation purpose)(713): pathologising normal behaviour, disempowering
individuals when subject to control by medical profes-
sionals or models of care, decontextualising experience,
and depoliticising social problems. As Parens argues,
‘insofar as medicine focuses on changing individuals’
bodies to reduce suffering, its increasing influence steals
attention and resources away from changing the social
structures and expectations that can produce such suffer-
ing in the first place’ (13). And medicalization incurs
substantial costs for health care treatments and side
effects: Conrad andcolleaguesrecentlyestimatedthecosts
of medicalization of 12 conditions to be $77 billion per
year in the United States alone (14).
Medicalization can occur at multiple levels (12)  for
example, at the level of interaction where individual
patients or doctors seek a medical label or apply a medical
solutiontoaproblem,oratahigherlevelwheredefinitions,
priorities,andagendasaresetandrecommendedstrategies
and resource allocations determined. Medicalization ana-
lyses are particularly valuable at this higher level (8),
helping uncover how certain issues in the health field get
defined, how others are excluded, how the solutions to
problems are constructed, and what agendas are pro-
moted. This iswhereitcomes in as a critical toolforglobal
health.
While medicalization analyses (almost exclusively con-
ducted in the Western context) have identified problems
with ‘creating’ diseases and patients, overlooking social
causes for ill health, and promoting pharmaceutical treat-
ments rather than broader political change, there is a need
to extend these analyses to explore the medicalization of
the global health agenda. As other scholars have affirmed,
it is of critical importance to examine the relationship of
medicine to emerging priorities and consensus on global
health. For example, some have highlighted that biomedi-
cal advances alone do not alleviate health problems, and
nor have technological solutions or the ability to ‘cure’ or
treat been responsible historically for public health gains
Box 1. Forms of medicalization.
Medicalization occurs when the biomedical model  the
modern, dominant form of practice by Western health care
professionals  is applied to the understanding of a pheno-
menon. A biomedical model sees health as freedom from
disease, and is characterised by reductionism, individ-
ualism, and a bias toward the technological.
Reductionism
 Ignores or excludes context and reduces explanations
for problems to the physical realm, overlooking social,
cultural, psychological, or environmental factors that
contribute to or influence why a phenomenon occurs (1).
 Depends upon normative ways of thinking that exclude
complexity, relativity, and multiplicity of experiences of
health.
 Seeks causes and solutions in biology rather than in
social or political forces, depending upon tests,
images, and diagnoses to treat deficiencies and restore
health (2).
 For example, in the classic case of the medicalization of
alcoholism that saw the previously deviant problem go
from ‘badness to sickness’, medical responses framed
the problem not as moral weakness or a social problem
but as a failure of biochemistry or genetics, and
developed medical strategies to treat the brain-based
condition (3).
Individualism
 Places the responsibility and sometimes blame for
problems with an individual rather than with structures
that shape or determine that individual’s behaviour or
experience.
 For example, Scott’s case of the medicalization of
shyness shows how a biomedical approach to shyness
‘reinforces the belief that this is a problem of individual
minds rather than a reflection of social norms and
values’ that expect assertiveness, self-confidence, and
gregarious participation in life; any deviation can and
should be ‘treated’ (4). Another example: Analyses of
the medicalization of attention deficit hyperactivity
disorder (ADHD) highlight medical values that cast
disruptive, inattentive behaviour of children into a
mental or brain disorder with treatments: the efficiency
of drug therapy, the interests and profits of drug
companies, and control of children’s behaviour (of
interest to classmates, teachers, and parents) (5).
 Can deflect attention away from the government’s role
or responsibility in addressing a problem and from
actions like industry marketing behaviour. For example,
in the medicalization of child malnutrition, Global Health
Watch criticises the UNICEF approach that focuses on
supplementation with ready-to-use foods and ignores
the economic constraints, poverty, barriers to
breastfeeding, food pricing, and trade policies that result
in mothers and children not receiving adequate and
sustained nutrition (6).
Technological bias
 It has its roots in the biomedical precept of the body as
machine, inspiring a focus on the curative elements of
medicine rather than preventative actions such as
changes in the environment (1).
 Technological imperative favours drug, device, or other
medical technologies or other ‘magic bullets’ to treat
problems.
 For example, analyses of the medicalization of death
show a natural state that has become more and more
under the purview of medicine and biotechnology, which
now regulates the circumstances and exact moment of
death (5). This control as been fought by proponents of
a more natural death, but across geography and class
the conditions of death and dying continue to be
medicalized (5).
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other social scientists (1821), have highlighted the
political determinants of health, demonstrating how the
concentration of power, ideology (such as neoliberalism),
and other dimensions of politics can have an enormous
impact on the health indicators and inequalities of
societies; examples include structural adjustment and
povertyreduction strategies, the decentralisation of health
systems, and other market-driven technical solutions that
grewout of neoliberal economic policies and are criticised
for distorting and negatively impacting global health and
development.Morecontemporaryworkbygroupssuchas
Global Health Watch (www.ghwatch.org), Go4Health
(22), and The Lancet  University of Oslo Commission
on Global Governance for Health (23) build on this
recognition of the political context of health to offer
critical analyses of the current global health policy agenda
and of the limits of medicine.
AsBenatarstates,themedicalizationofhealthproduces
‘too simplistic a view of making more modern medical
treatments available to more people’ (16). In the global
health context, medicalizing priority problems and solu-
tions may prove detrimental for how the world responds
andresourcesactionsdesignedtoalleviatepoorhealthand
poverty, redress inequities, and save lives. Examining
whether the global health agenda is being defined and
fashioned in thisway is particularly relevant in light of the
striking rise of global health.
The rise of global health
The field of global health is growing enormously in size
and profile. What was once a marginal field within
medicine and the health sciences is now an abundant
area of research, education, and policy, and has become
‘fashionable’ among students and practitioners (24).
Partly this is due to increased visibility of the levels of
preventable mortality and morbidity around the world,
especially the disproportionate burden of disease borne
by developing countries, recognition that a billion of the
poorest people in the world live in middle-income rather
than poor countries (25), and the fact that the global
epidemiological transition is creating a double burden of
infectious and chronic disease threats, highlighting how
social conditions of poverty and industrialisation com-
bine (26). Governments and international agencies have
recognised social and collective responsibility for improv-
ing the world’s health, as well as the links between
economic development and health, and as such the need
to invest effort into global health. High profile interna-
tional funding initiatives like GAVI and the Global Fund
to Fight AIDS, Tuberculosis and Malaria demonstrated
multi-lateral commitments to fighting common problems,
and the growth of philanthropic activity, especially the
enormous endowment of the Bill & Melinda Gates
Foundation, have put global health concerns on centre
stage. Between 1990 and 2008 donor funding to global
health dramatically increased from US$5.6 billion to 21.8
billion (27) and, despite the fiscal crisis of 2008, global
health financing expanded to $26.9 billion in 2010 (28).
While the breadth of global health problems concerns
multidisciplinary fields such as law, business, and public
policy, the profile of global health appears most elevated
by its expanded presence within medical institutions
including professional curriculum and medical journals.
In 2008, nearly half of all American medical schools had
some activity dedicated to global health (29), and in 2013
the Consortium of Universities for Global Health listed
over 100 university global health programmes in North
America; similar up-trends are occurring in Europe
and worldwide (30). Global health research and debate
now regularly appear in the highest impact weekly
medical journals, including BMJ, The Lancet, and
PLOS Medicine, which also often now editorialise and
campaign on matters of global health. More recently even
the clinically inclined US-based medical journals JAMA
and NEJM have developed sections on global health, and
several ‘specialist’ journals devoted to global health
research and practice (e.g. Global Health Action, Journal
of Global Health, and Lancet Global Health)h a v e
emerged to address growing interest and the needs of a
diverse global health community.
The global health agenda
Similarly, global health now occupies a central place in
the world’s development discussions, including a notable
presence at the 2013 United Nations General Assembly
(31), with the recognition that a healthy population is an
economically productive one. Addressing top develop-
ment issues like poverty, education, and environmental
sustainability is seen to require good health, and govern-
ments’ foreign policy, security, and humanitarian inter-
ests now link health with development. The commitment
of the UN’s 189 member states to the Millennium
Declaration led to the Millennium Development Goals
(MDG) programme, which defined eight development
targets, of which three were explicitly named as health
targets (reduce maternal and child deaths, and cut the
rate of HIV and malarial infections), and has galvanised
international attention, effort, and investment.
With the MDG end-date approaching, attention is
focused on the next round of development goals. ‘Post-
2015’ architects and campaigners look to learn from the
lessons of the MDG programme  what succeeded, what
failed, and how to optimise the place of health within the
development agenda for the next two decades. A plethora
of research, commentary, opinion, and reports of various
consultations and high-level meetings dominate global
health conversations and journals; leading issues include
universal health coverage and non-communicable diseases
including mental health. Amidst the flurry of activity to
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it seems clear that competition is fierce: contending
priorities must capture often elusive political momentum
and commitment, and must do so in light of global fiscal
restraint and increasing rivalry for attention and funding
on the international stage (28).
What kind of problem is global health?
So while health is considered a key ingredient for devel-
opment, how is ‘health’defined? This question is critically
important,particularlyinlightofthepredominanceglobal
health has on the post-2015 development agenda dis-
cussions, and for what it will imply for actions and policy
responses. One major on-going tension has been the
relative recognition of the social determinants of health.
Social determinants include income, education, employ-
ment, housing, nutrition, and other individual and social
factors that relate to ‘the conditions in which people are
born,grow,live,work,andage,andtheinequitiesinpower,
money, and resources that give rise to them’ (32). Their
importance to health has been recognised for decades and
enshrined in international declarations such as Alma Ata
(33), and much recent commentary (3437) has stressed
theimportanceofincludingsocialdeterminantsinthenew
health agenda post-2015 and critiqued the MDG pro-
gramme for failing to sufficiently address these underlying
causes of ill health and equity. Others broaden the lens
further and argue for attention to the wider political
context and systems, which Birn says are ‘the causes of the
causes of the causes’ (15). Similarly, Navarro and others
argue that no consideration of the determinants of health
is complete without examining the politics and power
relations of the system in which priorities emerge (1821).
Health, under this global political economy approach, is a
production of economic and trade policies, governance,
human rights protection, and other societal determinants
(15,16).Healthcare,dominatedbybiomedicine,isbutone
of multiple determinants of health.
Still, a medical definition of global health has been
evident in a variety of international initiatives: the multi-
lateral partnership of the Global Fund whose main
mission is to improve access to drugs for AIDS, malaria,
and tuberculosis rather than the living conditions that risk
and mitigate infection (16); the technological focus and
prioritiesoftheGatesFoundation(38);andthereduction-
ism of the various Grand Challenges programmes that are
said to overlook social, economic, and political contexts
(39). Benatar, for example, described the 2008 Institute of
MedicinereportontheUScommitmenttoglobalhealthas
regressive, admonishing the organisation for focusing on
‘aspects of health that can be classified medically and
treatedwith medications’ (16). Similarly, Sanders critiques
the DALYs approach to estimating the global burden of
disease for invariably focusing on medical technologies
rather than broader social interventions, such that World
Bank recommends oral rehydration salts for diarrhea
treatment, rather than basic provision of water and
sanitation, which is deemed ‘cost ineffective’ and unsui-
table for public sector investment (17).
The medicalization of global health: three cases
In three subsequent articles I build on these insights,
drawing on sociological theories of medicalization to
examine three contemporary issues on the current global
health agenda  global mental health movement (Paper
2) (40), non-communicable disease agenda (Paper 3) (41),
and the universal health coverage campaign (Paper 4)
(42). Specifically, I explore areas where these cases might
be medicalized: how they are framed as problems in
global health and what solutions are presented, to what
extent priority issues within these cases became defined as
diseases, whether and how strategies for treatment and
other health care solutions are offered, what the role of
medical providers or of a biomedical model is conceived
to be or promoted, and how the role of advocacy groups,
civil society, and/or industry reinforce, benefit, or chal-
lenge the medicalization of global health. The insights
generated offer an assessment as to whether the balance
between medical and social considerations are appro-
priate, why bias might occur, and what the implications
are for policy responses and strategies when the framing
of global health problems appear too medicalized. If the
definitions of global health problems are medicalized,
any solutions constructed will similarly be limited in
impact. Furthermore, medicalization needs more atten-
tion because it has a reproductive or ‘escalating’ aspect
that can be harmful: once defined in medical terms
(especially by powerful institutions), global health pro-
blems and solutions risk being framed as such repeatedly
and over time, thus reinforcing the medicalization of
global health.
Looking critically at the global health agenda is
necessarybecauseitsetsprioritiesandresourceallocation,
shapespublicperceptionsandpolicydecisions,anddefines
thenextgenerationofhopesandexpectationsforcollective
action tosave andimprove lives. AsKleinman hasrecently
argued (43), more critical reflection on global health
problems and programmes using social theories is needed,
to complement epidemiological, health services, policy,
and ethics studies. And D’Ambruoso specifically in re-
lation to the post-2015 global health agenda notes that:
‘more relevant, inclusive, interdisciplinary analytical fra-
meworksarerequiredtoimprovenotionsofwhatgoalsare
and what success looks like’ (36). Medicalization analyses
canprovidethatneededcriticalview.Whileusefulcritiques
have emerged from the many perspectives arguing that
the global health agenda overlooks social determinants
of health and equity (3437) and incisive analyses that
use social constructionist approaches (44, 45), political
economy(1721),orthe‘righttohealth’framework(46,47)
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advanced on policy agendas, none to my knowledge have
specifically used the lens of medicalization. As a critical
sociological tool, a medicalization lens provides avaluable
waytouncoversomeofthelimitationsandimplicationsof
the global health agenda.
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